Drug Development

Wai-Chi Man is IC/SP product marketing manager at Thermo Fisher Scientific.

Articles

Replacing a step in sample preparation with an automated approach improves both method precision and productivity.

Automating a Critical Step in Glycoprotein Analysis for Vaccine Manufacture

Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.

Steriline Showcases Filling Equipment at CPHI 2022

Gerresheimer has developed a new dropper insert for ophthalmic formulations that it is showcasing at CPHI 2022 in Frankfurt, Germany.

Gerresheimer Showcases DropControl, a New Dropper Solution for Ophthalmic Formulations, at CPHI 2022

South Africa’s vaccine regulator has reached new WHO level to ensure safety, quality, and effectiveness.

WHO Ranks South Africa’s Vaccine Regulatory System at a Functional Level of Maturity

Aenova Group and Microcaps are partnering to enable new customized formulations for product development and life cycle management solutions.

Aenova and Microcaps Enter Strategic Collaboration

The agency has recommended approval of Comirnaty and Spikevax for children from six months of age.

EMA Extends Use of COVID-19 Vaccines to Children

The agency has recommended authorization of the Spikevax COVID-19 vaccine that targets the Omicron variants BA.4 and BA.5.

EMA Recommends Adapted Spikevax Vaccine

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Podcasts

In this episode, Ana Ladino provides expert insight into novel excipients in the current and future drug development landscape.

Drug Solutions Podcast: Novel Excipients in Drug Development

Frédérique Bordes-Picard is vice-president of Business Development, Europe, at Nanoform.

Patient centricity is driving change in drug discovery and development, leading to a a new dawn in therapeutics.

Small is a Powerful Ingredient for Patient-Centric Formulations

Robert O. Williams III, PhD, is the division head and professor of molecular pharmaceutics and drug delivery at The University of Texas at Austin, College of Pharmacy; the Johnson & Johnson centennial chair in pharmacy at the University of Texas at Austin, College of Pharmacy; editor-in-chief of the AAPS PharmSciTech scientific journal; and the technology inventor/special advisor for TFF Pharmaceuticals.

How dry powder techniques can overcome limitations in biologics development and delivery to broaden routes of administration and global accessibility.

Formulation and Drug Delivery